As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Semnur Pharmaceuticals, Inc. The largest reported stake is Scilex Holding Company's, at 78.85%. 4 filings are on record since August 12, 2025 (Schedule 13D/A, June 26, 2026).
Sell to companies like Semnur Pharmaceuticals, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Scilex Holding Company · Sole voting: 500,000 · Shared voting: 181,020,112 · Sole dispositive: 500,000 · Shared dispositive: 181,020,112 · SCHEDULE 13D/A, 2026-06-26
- · Holder: Scilex Holding Company · Percent: 82.07% · SCHEDULE 13D/A
- · Reporting person: Meteora Capital, LLC · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13G/A, 2025-08-14
- · Reporting person: Td Securities (Usa) LLC · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13G/A, 2025-08-12
Semnur Pharmaceuticals, Inc. has 4 Schedule 13D or 13G filings on record since 2025-08-12. 1 holder's latest filing reports 5% or more of common stock, par value $0.0001. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Scilex Holding Company | 78.85% | 181,520,112 | SCHEDULE 13D/A, 2026-06-26 | 2026-06-15 |
| Td Securities (Usa) LLC | 0% | 0 | SCHEDULE 13G/A, 2025-08-12 | 2025-06-30 |
| Meteora Capital, LLC | 0% | 0 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
Holding shares or following this stake? See who's behind Semnur Pharmaceuticals, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Semnur Pharmaceuticals, Inc. and the records around it.
Companies that share a holder
- Scilex Holding Company also filed stake reports on 2 other companies: DATAVAULT AI INC. (Aug 2026), Semnur Pharmaceuticals, Inc. (Sep 2025)
- TD SECURITIES (USA) LLC also filed stake reports on 27 other companies: Cal Redwood Acquisition Corp. (Aug 2026), CANTOR EQUITY PARTNERS III, INC. (Aug 2026), GigCapital7 Corp. (Aug 2026)
- Meteora Capital, LLC also filed stake reports on 80 other companies: Dynamix Corp (Nov 2026), Investcorp Europe Acquisition Corp I (Oct 2026), 1RT Acquisition Corp. (Aug 2026)
Watch Semnur Pharmaceuticals, Inc.
Get an email when Semnur Pharmaceuticals, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Semnur Pharmaceuticals, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Semnur Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Semnur Pharmaceuticals, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Scilex Holding Company | 500,000 | 181,020,112 | 500,000 | 181,020,112 | SCHEDULE 13D/A, 2026-06-26 |
| Scilex, Inc. | 0 | 174,770,112 | 0 | 174,770,112 | SCHEDULE 13D/A, 2026-06-26 |
| Td Securities (Usa) LLC | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2025-08-12 |
| Cowen Financial Products LLC | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2025-08-12 |
| Toronto Dominion Holdings Usa Inc | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2025-08-12 |
| Td Group Us Holdings LLC | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2025-08-12 |
| Toronto Dominion Bank | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2025-08-12 |
| Meteora Capital, LLC | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2025-08-14 |
The latest filing identifies Semnur Pharmaceuticals, Inc. by CUSIP 81686G113 and gives its principal executive office as 960 San Antonio Road, Palo Alto, CA 94303 (SCHEDULE 13D/A, 2026-06-26).
Purpose of Transaction (Item 4)
Scilex Holding Company
Item 4 of the Schedule 13D is hereby supplemented as follows: On June 15, 2026, SHC and/or its subsidiaries distributed 7,034,737 shares of the Issuer's Common Stock as a dividend to holders of Scilex common stock and other eligible equity securities as of the record date of June 1, 2026 in connection with SHC's board-approved dividend declared on May 22, 2026.Item 4 of the SCHEDULE 13D/A filed 2026-06-26
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-12 | Td Securities (Usa) LLC | 0% | SCHEDULE 13G/A |
| 2025-08-14 | Meteora Capital, LLC | 0% | SCHEDULE 13G/A |
| 2025-10-14 | Scilex Holding Company | 82.07% | SCHEDULE 13D/A |
| 2026-06-26 | Scilex Holding Company | 78.85% | SCHEDULE 13D/A |
Questions about who owns Semnur Pharmaceuticals, Inc.
Who owns Semnur Pharmaceuticals, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Semnur Pharmaceuticals, Inc.: Scilex Holding Company (78.85%, Schedule 13D/A, filed 2026-06-26).
When did Scilex Holding Company buy into Semnur Pharmaceuticals, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Scilex Holding Company on this page is the Schedule 13D/A, filed 2025-10-14, reporting 82.07%; its latest, Schedule 13D/A filed 2026-06-26, reports 78.85%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Semnur Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.